AtriCure (NASDAQ:ATRC – Free Report) had its price objective increased by Oppenheimer from $36.00 to $45.00 in a report issued on Thursday morning,Benzinga reports. They currently have an outperform ...
AtriCure (NASDAQ:ATRC – Get Free Report) had its price target upped by stock analysts at Stifel Nicolaus from $36.00 to $48.00 in a report released on Thursday,Benzinga reports. The firm currently has ...
Atrial fibrillation (Afib) is an irregular and often rapid heartbeat that originates in the heart’s upper chambers (atria).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback